Huw Jones
Chief Executive Officer chez THERACRYF PLC
Fortune : 691 $ au 31/03/2024
Profil
Huw Jones is currently the Chief Executive Officer & Director at Evgen Pharma Plc, the Chairman at Chronos Therapeutics Ltd., and a Non-Executive Director at Ixaka Ltd.
He previously served as the Non-Executive Chairman at Sinclair Pharma UK Ltd.
from 2002 to 2006, as a Non-Executive Director at Ardana Plc from 2006 to 2010, and as the President at CV Therapeutics, Inc. Dr. Jones holds a doctorate degree from the University of Birmingham.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
THERACRYF PLC
0,02% | 14/12/2022 | 62 500 ( 0,02% ) | 691 $ | 31/03/2024 |
Postes actifs de Huw Jones
| Sociétés | Poste | Début |
|---|---|---|
| THERACRYF PLC | Chief Executive Officer | 01/10/2020 |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Chairman | - |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 12/02/2020 |
Anciens postes connus de Huw Jones
| Sociétés | Poste | Fin |
|---|---|---|
Sinclair Pharma UK Ltd.
 Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Chairman | 01/01/2006 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | President | - |
Ardana Plc
 Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Chief Executive Officer | - |
Formation de Huw Jones
| University of Birmingham | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| THERACRYF PLC | Health Services |
| Entreprise privées | 5 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
Sinclair Pharma UK Ltd.
Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Commercial Services |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
